Dr. Arnold graduated from Amherst College with a degree in neuroscience, followed by a medical degree from the University of California, Davis. After a medical internship at California Pacific Medical Center, Dr. Arnold completed his residency in neurology as well as fellowship training in movement disorders at the University of California, Los Angeles. He ins broad certified in neurology and is an assistant clinical professor at Touro University. He has practiced in the East Bay since 2007 and is active in the local movement disorders community. His main interest is the treatment and support of patients with Parkinson's disease and other movement disorders.
Sutter Health Research Enterprise
2850 Telegraph Avenue, Suite 110
Berkeley, CA, 94705
(510) 204-8140
ArnoldM2@sutterhealth.org
Primary Research Interests
Related Clinical Trials
GN41791
A PHASE III MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE DUMMY, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB IN ADULTS WITH PROGRES
Investigators: Matthew W. Arnold M.D., David Eric Collins MD, Joanna A. Cooper M.D., Aryn Earnhardt NP, Lynn Jehle NP, Antonio J Silva-Sayago MD, Bradley T Wrubel MD
Status: Active, Not Recruiting
Novartis CLOU064C12301 REMODEL-1
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Rela
Investigators: Matthew W. Arnold M.D., Joanna A. Cooper M.D., Lynn Jehle NP, Deepak Soneji MD, Bradley T Wrubel MD
Status: Active, Recruiting
TOPAZ
Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's D
Investigators: Matthew W. Arnold M.D., Erica A. Byrd M.D., Nicklesh Thakur MD
Status: Active, Recruiting